Further re Corporate Update

Sondrel (Holdings) plc
01 March 2024
 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the UK Market Abuse Regulation

 

1 March 2024

 

Sondrel (Holdings) plc

("Sondrel", the "Company" and together with its subsidiaries the "Group")

 

Further re Corporate Update

 

Further to the announcement on 27 February 2024, Sondrel confirms that discussions with a potential provider of capital to meet the Group's immediate working capital requirements are now at a very advanced stage in respect of a proposed £0.9 million secured 15% convertible loan note (the "CLN").

 

If agreed between the parties, the CLN would be mandatorily convertible into new ordinary shares in the Company at a price of 10 pence per new ordinary share on completion of a wider fundraise by the Company to raise net proceeds of not less than c.£6 million (the "Fundraise"). The provider of the CLN is expected to invest a further material equity amount in the Fundraise, which is intended to be completed prior to the end of March 2024.

 

The Fundraise is expected to provide the Company with the necessary working capital resources to support it through to a positive trading cash flow position in the year ending 31 December 2024 ("FY24").

 

Whilst the CLN is expected to be secured imminently, the Company cautions that the provision of the CLN remains subject to agreement between the parties. The Company will not be able to meet February 2024 payroll in full prior to receipt of CLN proceeds.

 

The Company thanks its employees and other stakeholders for their continued support and commitment to the Group and further announcements will be made, as appropriate, in due course.

 

 

For further information:

 

Sondrel (Holdings) plc

Via Buchanan

Graham Curren, CEO

Tel: +44 (0) 20 7466 5000

Nick Stone, Interim CFO




Cavendish Capital Markets Limited

Tel: +44 (0) 20 7220 0500

Ben Jeynes / Katy Birkin / George Lawson - Corporate Finance


Michael Johnson - Sales




Buchanan Communications

Tel: +44 (0) 20 7466 5000

Chris Lane / Stephanie Whitmore / Abby Gilchrist

sondrel@buchanan.uk.com

 



 

About Sondrel

Sondrel is a UK-based fabless semiconductor company specialising in high end, complex digital Application Specific Integrated Circuits (ASICs) and System on Chips (SOCs). It provides a full turnkey service in the design, prototyping, testing, packaging and production of ASICs and SoCs.

 

The Company is one of only a few companies capable of designing and supplying the higher-spec chips built on the most advanced semiconductor technologies, selling into a range of hyper growth end markets such as high-performance computing, automotive, artificial intelligence, VR/AR, video analytics, image processing, mobile networking and data centres.  Sondrel designs have enabled products by leading technology brands including Apple (iPhone), Sony (PlayStation), Meta's (Oculus), Samsung, Google and Sony smartphones, JVC (prosumer camcorders), Tesla and Mercedes-Benz cars.

 

Sondrel is well-established, with a 20-year track record of successful delivery, supported by long standing ecosystem partnerships including Arm, TSMC and Samsung. Headquartered in the UK, Sondrel has a global presence with offices in UK, USA, China, India and Morocco.

 

For more information please visit: www.sondrel.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100